Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay

Cancer Treat Rep. 1983 Feb;67(2):173-8.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acenaphthenes
  • Alkaloids / therapeutic use*
  • Animals
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical / methods*
  • Evaluation Studies as Topic
  • Harringtonines / therapeutic use*
  • Harringtonines / toxicity
  • Homoharringtonine
  • Humans
  • Kidney
  • Mice
  • Neoplasm Transplantation
  • Neoplasms / drug therapy*
  • Ribonucleotides / therapeutic use*
  • Ribonucleotides / toxicity

Substances

  • Acenaphthenes
  • Alkaloids
  • Harringtonines
  • Ribonucleotides
  • triciribine phosphate
  • Homoharringtonine